India's medicinal landscape is witnessing a substantial rise in API production houses. Fueled by increasing global need and favorable government policies, the country’s drug manufacturing sector has arisen as a key contributor to the international pharmacy supply chain. This surge is creating numerous possibilities for investment and employment a